High quality products to support Pathologists and Biological and Environmental Scientists
Control for SARS-CoV-2 Serologic Assay
$250.00Mixture of recombinant humanized IgG and IgM monoclonal antibodies directed against the NP protein of SARS-CoV-2 virus. This serves as an excellent and harmless positive control for Anti-SARS-CoV-2 immunoassays.
SARS-CoV-2 Antibody Assay
$450.00This is an Antibody Serologic Assay (SCSA) for SARS-CoV-2.
This test has not been reviewed by the FDA.
The SARS-CoV-2 Antibody rapid test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM/IgG anti-SARS CoV-2 antibody which may be found in samples such as serum, plasma, whole blood or cell culture media. This product is suitable for screening for the presence of SARS-CoV-2 reactive antibody in a Research Use Only Fashion.
Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
SARS-CoV-2 Antigen Assay (SCAA)
$125.0025 tests per kit.
Used for in vitro qualitative detection of SARS-CoV-2 antigens in human swabs samples (Nasopharyngeal swab and oropharyngeal swab). It can only be used as a supplementary test indicator for suspected cases with negative PCR test of SARS-CoV-2 or used in conjunction with PCR testing in the diagnosis of suspected cases.